Oxford Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-400,000
Closed -$17.3M 1034
2015
Q3
$17.3M Buy
+400,000
New +$16.9M 0.54% 26
2015
Q1
Sell
-41,253
Closed -$1.4M 828
2014
Q4
$1.4M Sell
41,253
-38,693
-48% -$1.37M 0.03% 432
2014
Q3
$2.77M Buy
+79,946
New +$2.74M 0.06% 311
2014
Q1
Sell
-174,074
Closed -$6.68M 867
2013
Q4
$6.68M Sell
174,074
-136,508
-44% -$4.31M 0.17% 177
2013
Q3
$8.51M Sell
310,582
-227,666
-42% -$5.39M 0.19% 127
2013
Q2
$11.3M Buy
+538,248
New +$10.5M 0.31% 68

Other funds holding WX

Oxford Asset Management's WX Position: Q4 2015 in Review

Oxford Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 400,000 shares — an estimated $17.3M sold.

Oxford Asset Management first reported a position in WX in Q2 2013 and held it in 6 quarters. The position peaked at $17.3M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Oxford Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Oxford Asset Management sold 400,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $17.3M.
  • Oxford Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 6 quarters.
  • Oxford Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $17.3M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Oxford Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.